Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
USA116th CongressS-3353| Senate
| Updated: 2/27/2020
Bill Cassidy
Republican Senator
Louisiana
Cosponsors (25)
Joni Ernst (Republican)Jeanne Shaheen (Democratic)Rick Scott (Republican)Mike Braun (Republican)Richard J. Durbin (Democratic)David Perdue (Republican)Kirsten E. Gillibrand (Democratic)Todd Young (Republican)Tom Cotton (Republican)James M. Inhofe (Republican)Michael B. Enzi (Republican)John Boozman (Republican)Kyrsten Sinema (Independent)Sheldon Whitehouse (Democratic)Chris Van Hollen (Democratic)James Lankford (Republican)Jon Tester (Democratic)Tina Smith (Democratic)Sherrod Brown (Democratic)John Cornyn (Republican)Benjamin L. Cardin (Democratic)Marco Rubio (Republican)Patrick Toomey (Republican)Steve Daines (Republican)Shelley Moore Capito (Republican)
Finance Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant. Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Health
Congressional oversightDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedicareOrgan and tissue donation and transplantationPrescription drugs
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
USA116th CongressS-3353| Senate
| Updated: 2/27/2020
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant. Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Bill Cassidy
Republican Senator
Louisiana
Cosponsors (25)
Joni Ernst (Republican)Jeanne Shaheen (Democratic)Rick Scott (Republican)Mike Braun (Republican)Richard J. Durbin (Democratic)David Perdue (Republican)Kirsten E. Gillibrand (Democratic)Todd Young (Republican)Tom Cotton (Republican)James M. Inhofe (Republican)Michael B. Enzi (Republican)John Boozman (Republican)Kyrsten Sinema (Independent)Sheldon Whitehouse (Democratic)Chris Van Hollen (Democratic)James Lankford (Republican)Jon Tester (Democratic)Tina Smith (Democratic)Sherrod Brown (Democratic)John Cornyn (Republican)Benjamin L. Cardin (Democratic)Marco Rubio (Republican)Patrick Toomey (Republican)Steve Daines (Republican)Shelley Moore Capito (Republican)
Finance Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedicareOrgan and tissue donation and transplantationPrescription drugs